Skip to main content

Want a detailed portfolio tracker?

Deciphera Pharmaceuticals (DCPH) Total Debt (2017 - 2024)

Deciphera Pharmaceuticals (DCPH) total debt from Sep 30, 2017 to Mar 31, 2024. The current Deciphera Pharmaceuticals (DCPH) total debt is $105M. You can adjust inflation or export chart.

Total Debt

Total Debt

Deciphera Pharmaceuticals (DCPH) Total Debt CAGR table

PeriodCAGR
1 Year TTM+5.50%
3 Years TTM+8.84%
5 Years TTM+26.44%
All Time TTM+29.94%

Annual Total Debt change of Deciphera Pharmaceuticals (DCPH)

YearTotal DebtChange
2023$123M
+9.17%
2022$112M
-9.95%
2021$125M
+26.33%
2020$99M
+30.05%
2019$76M
+113.43%
2018$36M
+135.32%
2017$15M
N/A

Comparison Deciphera Pharmaceuticals (DCPH) total debt with competitors

Deciphera Pharmaceuticals (DCPH) total debt is $104.88M.

TickerNameTotal DebtUpside
CABRCaring Brands Inc$384473.00-99.63%
RGCRegencell Bioscience Holdings Ltd$895308.00-99.15%
APUSApimeds Pharmaceuticals US Inc$1.09M-98.96%
INMInMed Pharmaceuticals Inc$2.24M-97.86%
PRFXPRF Technologies Ltd$2.71M-97.42%
YCBDcbdMD Inc$2.97M-97.17%
IXHLIncannex Healthcare Ltd$5.05M-95.19%
GELSGelteq Ltd$5.67M-94.59%
SXTCChina SXT Pharmaceuticals Inc$6.22M-94.07%
SBFMSunshine Biopharma Inc$6.41M-93.88%
CRDLCardiol Therapeutics Inc - Class A$7.22M-93.11%
CPHIChina Pharma Holdings Inc$8.12M-92.26%
SHPHShuttle Pharmaceuticals Holdings Inc$8.46M-91.93%
BGMQilian International Holding Group Ltd - Class A$8.91M-91.50%
DRRXDurect Corp$9.00M-91.42%
SNOASonoma Pharmaceuticals Inc$10.19M-90.28%
TXMDTherapeuticsMD Inc$10.61M-89.89%
TLPHTalphera Inc$11.68M-88.87%
EVOKEvoke Pharma Inc$12.29M-88.28%
BIOABioAge Labs Inc$18.53M-82.33%
BFRIBiofrontera Inc$18.72M-82.15%
AMLXAmylyx Pharmaceuticals Inc$20.44M-80.51%
RMTIRockwell Medical Inc$21.57M-79.44%
IMCCIM Cannabis Corp$28.80M-72.54%
TKNOAlpha Teknova Inc$33.73M-67.84%
SCYXScynexis Inc$36.32M-65.37%
CRONCronos Group Inc$48.30M-53.95%
CPIXCumberland Pharmaceuticals Inc$49.69M-52.62%
DERMJourney Medical Corp$60.70M-42.12%
CTORCitius Oncology Inc$65.43M-37.61%
ETONEton Pharmaceuticals Inc$67.09M-36.03%
SIGASIGA Technologies Inc$67.77M-35.39%
AYTUAytu BioPharma Inc$100.72M-3.97%
AVDLAvadel Pharmaceuticals plc$101.22M-3.49%
KMDAKamada Ltd$123.63M+17.88%
ZYBTZhengye Biotechnology Holding Ltd$129.76M+23.72%
ASRTAssertio Holdings Inc$135.67M+29.35%
ORGOOrganogenesis Holdings Inc - Class A$138.65M+32.19%
BTAIBioXcel Therapeutics Inc$139.57M+33.07%
OGIOrganiGram Holdings Inc$149.89M+42.91%
AQSTAquestive Therapeutics Inc$175.18M+67.03%
LFCRLifecore Biomedical Inc$204.72M+95.20%
ACBAurora Cannabis Inc$207.47M+97.81%
KNSAKiniksa Pharmaceuticals International plc. - Class A$219.59M+109.38%
EOLSEvolus Inc$249.43M+137.82%
LQDALiquidia Corp$292.95M+179.32%
INCRINC Research Holdings Inc$294.19M+180.51%
AKBAAkebia Therapeutics Inc$335.14M+219.55%
CGCCanopy Growth Corporation$348.02M+231.83%
XERSXeris Biopharma Holdings Inc$379.00M+261.37%
HROWHarrow Inc$391.19M+272.99%
DVAXDynavax Technologies Corp$412.37M+293.18%
SUPNSupernus Pharmaceuticals Inc$423.92M+304.20%
HCMHUTCHMED (China) Ltd$534.02M+409.17%
TLRYTilray Brands Inc$549.12M+423.57%
PCRXPacira BioSciences Inc$554.64M+428.83%
ESPREsperion Therapeutics Inc$770.46M+634.61%
EBSEmergent Biosolutions Inc$797.30M+660.20%
UTHRUnited Therapeutics Corp$813.10M+675.27%
ANIPANI Pharmaceuticals Inc$859.67M+719.67%
AMPHAmphastar Pharmaceuticals Inc$874.77M+734.07%
EVOEvotec SE$941.17M+797.38%
BCRXBiocryst Pharmaceuticals Inc$1.02B+871.49%
PAHCPhibro Animal Health Corp - Class A$1.08B+932.89%
LNTHLantheus Holdings Inc$1.13B+981.52%
COLLCollegium Pharmaceutical Inc$1.34B+1177.21%
INDVIndivior Plc$1.34B+1178.60%
NBIXNeurocrine Biosciences Inc$1.50B+1329.06%
PBHPrestige Consumer Healthcare Inc$1.61B+1432.03%
ALVOAlvotech$1.70B+1524.22%
HIMSHims & Hers Health Inc - Class A$1.82B+1636.15%
ALKSAlkermes plc$2.51B+2289.92%
PRGOPerrigo Company plc$5.48B+5129.31%
ELANElanco Animal Health Inc$6.72B+6309.23%
ZTSZoetis Inc - Class A$11.92B+11266.32%
UPCUniverse Pharmaceuticals Inc$13.17B+12460.96%
HLNHaleon plc$16.12B+15267.68%
VTRSViatris Inc$22.18B+21045.02%
BHCBausch Health Companies Inc$25.58B+24289.78%
TEVATeva- Pharmaceutical Industries Ltd$31.81B+30228.95%
RDYDr. Reddy`s Laboratories Ltd$194.95B+185780.56%
TAKTakeda Pharmaceutical Company$597.16B+569273.57%